There was a significant reduction in the expression of the proliferation marker Ki67 in the drug-treated mice (Figure 5A,B), and decreased expression of several cell cycle markers including CCND1 (Figure 5C,D), and E2F1 (Figure 5E,F), which could account for the reduction in tumor weight in response to Bay. The gene discussed is MKI67; the disease is neoplasm.